[1] CHANG G W, KAM P C. The physiological and pharmacologicalnroles of cytochrome P450 isoenzymes[J]. Anaesthesia,1999,54(1):42-50. [2] LEUCUTA S E, VLASE L. Pharmacokinetics and metabolic drug interactions[J].Current clinical pharmacology, 2006,1(1):5-20. [3] 郭晓昕,杜晓曦,薛松林.从美国药品撤市看药品安全风险管理[J].中国药物警戒, 2011, 2(04): 212-216. [4] 张石革, 宋菲. 回顾若干处方药的淘汰史,重视药物的临床再评价[J].中国医院用药评价与分析, 2002,8(04): 195-198. [5] ALFARO C L. Emerging role of drug interaction studies in drug development:the good, the bad, and the unknown[J]. Psychopharmacology bulletin, 2001, 35(4): 80-93. [6] FDA. Guidance for Industry Drug Interaction Studies-Study Design, Data Analysis, and Implications for Dosing and Labelinge.Draft Guidance[EB/OL].(2006-09-11).[2010-11-01].http://wwwfdagov/cder/guidance/indexhtm, 2006. [7] ZHANG L, REYNOLDS K S, ZHAO P, et al. Drug interactions evaluation: an integrated part of risk assessment of therapeutics[J]. Toxicol Appl Pharmacol, 2010, 243(2): 134-145. [8] BREIMER D D, SCHELLENS J H. A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans[J].Trends Pharmacol Sci, 1990, 11(6): 223-225. [9] CHAURET N, GAUTHIER A,NICOLL-GRIFFITH D A. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes[J]. Drug Metab Dispos, 1998, 26(1): 1-4. [10] BUSBYWF, JR., ACKERMANN J M, et al. Effect of methanol,ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450[J]. Drug Metab Dispos, 1999, 27(2): 246-249. [11] HE F, BI H C, XIE Z Y, et al. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids[J]. Rapid communications in mass spectrometry: RCM,2007, 21(5): 635-643. [12] TURPEINEN M, UUSITALO J, JALONEN J, et al. Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay[J]. Eur J Pharm Sci, 2005, 24(1): 123-132. [13] WUJ, HUGHESC S, PICARDP, et al. High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandemmass spectrometry[J].Anal Chem, 2007, 79(12): 4657-4665. [14] SHADERRI,GRANDABW,VONMOLTKE LL, et al. Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast [J].Biopharm Drug Dispos,1999, 20(8): 385-388. [15] TESTINO S A, JR., PATONAY G. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry[J]. J Pharm Biomed Anal, 2003, 30(5): 1459-1467. [16] 王丹,刘萍霞,张振清,等.LC-MS/MS 同时测定6 种CYP450 探针药物及快速评价小鼠CYP450 同工酶活性[J].军事医学科学院院刊, 2008,32(6):545-549. |